—
Join our Pi3 kinase mutated tumor clinical trial  

Take control of your fight with Faeth. Our science-backed precision nutrition program is designed to starve your cancer of the nutrients it needs to survive and grow. Our preclinical animal studies have shown that our program may also increase the effectiveness of standard treatments.

​

FTH 001 - A Phase 1b Study of Serabelisib in Combination with an Insulin Suppressing Diet (Study ISD) in Adult Subjects with Advanced Solid Tumors with PIK3CA Mutations with or without PTEN loss

​

Locations

Memorial Sloan Kettering, New York NY

646-888-4224

makkerv@mskcc.org

Mayo Clinic, Rochester MN

855-776-0015

MAYOCLINICCANCERSTUDIES@mayo.edu

University of Texas Southwestern, Dallas TX 

214-648-7097

martha.cruz@utsw.edu

Pacific Cancer Specialists, Anaheim CA 

714-999-1465

elizabethg@pacificcancer.com

Hoag, Orange County CA

949-557-0290

cari.nelson@hoag.org

University of Alabama, Birmingham AL

205-975-2362

jspratlin@uabmc.edu

Medical College of Wisconsin, Milwaukee WI

414-805-6800

cccto@mcw.edu

East Carolina University, Greenville NC

252-816-2273

hemoncclinicaltrials@ecu.edu

University of Chicago, Chicago IL 

773-702-1000

cancerclinicaltrials@bsd.uchicago.edu

University of Pennsylvania, Philadelphia PA 

​

You may still be able to participate in a study if you are not being treated at one of these sites. To find out if you may still be eligible, please reach out to our clinical trial partner, Anova Evidence at (224)-218-2408 or faeth@anovaevidence.com.

Questions? Contact us, we're here to help

We are committed to your fight, and to creating better cancer treatments for you and many others like you in the future.

 

Learn more at ClinicalTrials.gov